Thus, further research in the interaction of macrophages with fibrin–fibronectin complexes is needed and could ultimately lead to the identification of treatment targets that inhibit the recruitment of regenerative macrophages to metastatic tumor cells. The gene discussed is FN1; the disease is neoplasm.